Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Add-back capsule

Aliases
Add-back capsule (E2 1 mg / NETA 0.5 mg)

3 clinical trials

1 indication

Indication
Endometriosis
Clinical trial
A Double-blind Randomized Extension Study to Assess the Long-term Efficacy and Safety of Linzagolix in Subjects With Endometriosis-associated Pain
Status: Completed, Estimated PCD: 2022-09-15
Clinical trial
A Double-blind Randomized Extension Study to Assess the Long-term Efficacy and Safety of Linzagolix in Subjects With Endometriosis-associated Pain
Status: Terminated, Estimated PCD: 2021-01-08
Clinical trial
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain.
Status: Completed, Estimated PCD: 2021-10-18